We are live on ! Find out more
EVGN icon

Evogene

16 hedge funds and large institutions have $52.2M invested in Evogene in 2015 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 4 increasing their positions, 3 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

33% more repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 3

7% more funds holding

Funds holding: 1516 (+1)

0% more capital invested

Capital invested by funds: $52M → $52.2M (+$213K)

0.11% more ownership

Funds ownership: 2.23%2.34% (+0.11%)

Holders
16
Holders Change
+1
Holders Change %
+6.67%
% of All Funds
0.43%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
1
Increased
4
Reduced
3
Closed
Calls
Puts
Net Calls
Net Calls Change

EVGN Hedge Fund Activity: Q1 2015 in Review

16 of the 3,754 institutional investors tracked by Wall St. Rank reported a position in Evogene (EVGN) for Q1 2015, worth a combined $52.2M — up 0.41% from $52M a quarter earlier.

Buyers outnumbered sellers: 1 fund opened new EVGN positions and 0 closed out — a net gain of 1 holder — while 4 added to existing stakes and 3 trimmed.

The largest buyer was Vanguard Group, opening a new position worth an estimated $1.89M. The largest seller was JP Morgan Chase, cutting an estimated $39.1K.

  • 16 institutional investors held Evogene (EVGN) as of Q1 2015, up from 15 in Q4 2014.
  • Funds reported $52.2M of Evogene stock for Q1 2015, up 0.41% quarter-over-quarter.
  • 1 fund opened new Evogene positions in Q1 2015 and 0 closed out, a net change of +1 holder.
  • The largest Evogene buyer in Q1 2015 was Vanguard Group, an estimated $1.89M added.
  • The largest Evogene seller in Q1 2015 was JP Morgan Chase, an estimated $39.1K sold.

Based on aggregated 13F filings for Q1 2015.